Cure Congenital Muscular Dystrophy Research Grants
Cure CMD Research Grant Goals
Cure CMD research goals reflect our mission to bring research, treatments and in the future, a cure for the congenital muscular dystrophies.
1. Identify new therapeutic targets in the CMDs
2. Identify small molecule compounds that work at these therapeutic target sites with priority towards drugs with existing pediatric FDA approval
3. Facilitate the drug development process to ensure that each positive drug identification with promising preliminary data can be brought rapidly to preclinical trials and subsequent treatment trials
4. Support and endorse clinical research, infrastructure and biomarker discovery required to launch effective and efficient clinical trials in rare disease
5. Advance drug discovery with a diverse treatment pipeline
6. Support new scientific investigators with innovative ideas and a commitment to CMD research
Struggle Against Muscular Dystrophy (S.A.M) CMD Translational Research Grant: Annual Deadline, Sept 15th.
S.A.M is a unique CMD advocacy group launched by two parents whose son has CMD. SAM’s focus is to support and foster CMD research through successful fundraising initiatives. The SAM Translational Research Award delivers upon its promise to target research focused on CMD treatment. The grant is made possible through Cure CMD and SAM collaboration and the Cure CMD research grant funding mechanism.
Cure CMD and SAM invite proposals to award a 1-2 year grant focusing on pre-clinical and clinical investigations that will advance treatment for congenital muscular dystrophy (CMD). The total award is limited to $100,000 (direct costs only). Annual RFA deadline Sept 15th. Grant application above. On the First Page of the Cure CMD grant application, please specify S.A.M. CMD Translational Research Grant
Cure CMD General Research Grants: Annual Deadline Sept 15th.
Elisabeth Giauque Short Term CMD Research Grant: Cure CMD provides a short-range or “seed” grant (usually $25,000- $50,000 per year for 1-2 years, direct costs only) to attract new investigators to the CMD field and assist existing investigators to support early phases of their research. The short-range grant focus is to collect preliminary data and test initial hypotheses. The short-range grant goal is to translate successful preliminary research to either second tier Cure CMD midrange grants (R-21 type) or third tier, long range (R-01 grants, 2-5 years) from outside funding sources, such as the National Institutes of Health. Annual RFA deadline, Sept 15th. Grant application above. On the first page of the Cure CMD grant application, please specify Elisabeth Giauque Short Term CMD Research Grant.
info@curecmd.com
Cure CMD
P.O. Box 701
Olathe, KS 66051
Ph. 1-866-400-3626
